All In MedTech

Device Trial Radar · NCT03963284

Evaluation of AKI by Measuring the NephroCheck Test After Pediatric Cardiac Surgery

Evaluation of the Incidence of Renal Stress by Measuring the NephroCheck Test After Pediatric Cardiac Surgery

Last checked: Nov 20, 2026Latest source record: May 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

350

Planned (sponsor's estimate)

Start

Jun 2019

Primary completion

Dec 2019

Study completion Jun 2020

Sponsor

Lead sponsor
Shanghai Children's Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
BioMérieux
First posted
May 24, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 28 days, up to 3 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Blood and urine samples of over 200 pediatric subjects (over 28 days to 3 years) undergoing complex cardiac surgery with cardiopulmonary bypass (CPB) will be collected at several time points to measure corresponding biomarkers such as serum creatinine, serum urea concentration, or NephroCheck test (\[TIMP-2\]\*\[IGFBP7) to evaluate the diagnostic performance of AKI by NephroCheck test .

Conditions

  • Acute Kidney Injury
  • Cardiac Disease
  • Surgery

Interventions

  • cardiac surgeryProcedure

    pediatric cardiac surgery with cardiopulmonary bypass

  • NephroCheck testDevice

    Urine of the subjects undergoing cardiac surgery with CPB will be tested by NephroCheck test

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Test fresh urine samples by NephroCheckTime frame: up to one year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.